Click here to view this e-mail in a browser.
Conference Brief

DAY 3 - Tuesday, May 6


IOP more dynamic than thought

The typical eye undergoes 12,000 IOP spikes per hour while awake, and about 3,000 spikes per hour when sleeping, according to J. Crawford Downs, PhD. » MORE


Ranibizumab: Long-term stability for DME

In roughly 25% of patients, no further treatment was required to maintain mean visual acuity (VA) outcomes achieved at the exit of the RIDE/RISE 3-year core studies evaluating the efficacy of ranibizumab in patients with diabetic macular edema (DME), according to Allen Ho, MD. » MORE


Cataract surgery costs low at Aravind

Due to the extraordinarily high volume and minimal surgeon time, the average cataract cost—including IOL choice—ranges from $41 to $125 at India's Aravind Eye Hospital, said David W. Hutton, PhD. » MORE

Study: Accommodative lens less than stellar

An evaluation of 4 randomized clinical trials found no evidence to recommend the use of accommodative IOLs, said Hon Shing Ong, MBBS. » MORE


Regeneron, Avalanche join for gene therapy

Regeneron Pharmaceuticals and Avalanche Biotechnologies announced a collaboration to discover, develop, and commercialize novel gene therapy products for the treatment of ophthalmologic diseases. » MORE

This information has been independently developed and provided by the editors of Ophthalmology Times. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.

Amy Gallant Sullivan @Eyeppl

Glimpse from #ARVO2014 ...Working hard in #vision #science! #innovation #eyehealth #health #eyeinfo #medtech #research

U-M KelloggEyeCenter@UMKelloggEye

Racial Disparities in Ancillary Testing for Common Retinal Diseases #ARVO2014 #KECresearch

Brandon Lujan, MD @OCTMD

Amazing Split-Detection AO images from Alf Dubra #ARVO2014

Top Tweets

We welcome your feedback!
Please send your comments to:

Mark L. Dlugoss

Group Content Director

Advanstar Eye Health Group